Bulletin du Cancer
Volume 86, issue 9, Septembre 1999
Articles originaux
Decision committees in oncology: from standard to actual cases
(p.767-72)
Catherine Sauvagnac, Véronique Beckendorf, Anne Lesur, Elizabeth Luporsi, Joseph Stines, Pierre Falzon, Pierre Bey
Endothelin receptors in benign human tumours of uterine muscle
(p.773-8)
Michelle Breuiller-Fouché, Jean-Claude Honoré, Brigitte Robert, Thérèse Fournier, Marie-Cécile Vacher-Lavenu, Charles Chapron, Jean-Bernard Dubuisson, Françoise Ferré
Synthèses
Bisphosphonates and bone metastases
(p.732-8)
Alain Lortholary, Eric Jadaud, Patrice Berthaud
Adult’s anaplastic CD30+ large cell lymphomas
(p.739-44)
Laurent Cany, Pierre Soubeyran, Vincent Boulanger, Isabelle Soubeyran, Pierre Richaud, Houchingue Eghbali, Bernard Hoerni
Initial medical treatment for breast cancer
(p.745-52)
Etienne C.G. Brain, Jean-Louis Misset, Jacques Rouëssé
Point sur…
Multiple actions of EGCG, the main component of green tea
(p.721-4)
Gilles L’Allemain
beta-catenin mutations in a common skin cancer : pilomatricoma
(p.725-6)
Matthieu Durand, Jean-Pierre Molès
A multitargeted antifolate (MTA)
(p.727-31)
Amélie Lansiaux, Marian Degardin, Christian Bailly
Débat : Mastectomie prophylactique ?
The goals and limits of the debat
(p.753)
Nicolas Janin, Dominique Stoppa-Lyonnet
Under what conditions should we propose a prophylactic mastectomy for a woman at risk?
(p.754-9)
Marion Gauthier-Villars, Cécile Blandy, Dominique Stoppa-Lyonnet
For what reasons should we avoid suggesting a prophylactic mastectomy for a woman at risk?
(p.760-6)
Nicolas Janin
Compte rendu de congrès
35th annual meeting of the ASCO
(p.779-81)
Laurent Zelek, Marc Spielmann, Jean-Philippe Metges
Second annual meeting of the American Society of Gene Therapy (ASGT)
(p.782-6)
Mireia Pelegrin